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Introduction
Medulloblastoma is the most common malignancy of
the central nervous system in childhood. With the cur-
rent combined treatment with surgery, chemotherapy
and radiotherapy, the survival rates had improved dra-
matically in recent years. However, these survivors are
prone to develop various late sequelae secondary to
treatment.
Objective
The aim of this study is to assess the rate and the nat-
ure of endocrine complications among medulloblastoma
survivors in a single center.
Patients and methods
A retrospective chart review of patients with medullo-
blastoma managed in the department of Paediatrics and
Adolescent Medicine, Queen Mary Hospital, Hong
Kong, between January 1994 to June 2012 was per-
formed. Patients who had follow-up of less than 2 years
were excluded from the study.
Results
Thirty-four patients were included in the study. The
median age at diagnosis was 7.5 years (range = 0.8 -
17.2 years) and the median follow-up time was 10.45
years (range = 2 – 18.3 years). Hypothyroidism was
diagnosed in 16 patients (Primary hypothyroidism = 5
patients; compensated hypothyroidism = 10 patients;
central hypothyroidism = 1 patients) and it was the
commonest endocrine complication among this group
of patients. The median time to develop hypothyroidism
was 50 months (range = 15-155 months) from diagnosis.
Male sex was the only risk factor that was found to be
associated with the development of hypothyroidism
(OR= 3.14; p = 0.031). Eight patients developed growth
hormone deficiency and eight patients developed gona-
dal dysfunction. Age at diagnosis, dose and fractions of
radiotherapy, chemotherapy regimen and duration of
follow-up were all not associated with the development
of these complications.
Conclusions
Hypothyroidism is a common late complication among
medulloblastoma survivors. Patients could present with
minimal symptoms but it could be easily screened and
treated. Therefore, thyroid function test should be regu-
larly monitored among this group of patients.
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